595 related articles for article (PubMed ID: 31542510)
21. Mutational signatures and mutagenic impacts associated with betel quid chewing in oral squamous cell carcinoma.
Su SC; Chang LC; Lin CW; Chen MK; Yu CP; Chung WH; Yang SF
Hum Genet; 2019 Dec; 138(11-12):1379-1389. PubMed ID: 31679052
[TBL] [Abstract][Full Text] [Related]
22. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
23. Interaction Between Rare Variants in NOTCH1 and Betel Quid Chewing in Oral Squamous Cell Carcinoma.
Chung CM; Lee CH; Chen MK; Tsai MH; Ko YC
Genet Test Mol Biomarkers; 2017 Oct; 21(10):608-612. PubMed ID: 28910158
[TBL] [Abstract][Full Text] [Related]
24. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
25. Roles of FGFR in oral carcinogenesis.
Xie X; Wang Z; Chen F; Yuan Y; Wang J; Liu R; Chen Q
Cell Prolif; 2016 Jun; 49(3):261-9. PubMed ID: 27218663
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway.
Chai AWY; Yee PS; Price S; Yee SM; Lee HM; Tiong VK; Gonçalves E; Behan FM; Bateson J; Gilbert J; Tan AC; McDermott U; Garnett MJ; Cheong SC
Elife; 2020 Sep; 9():. PubMed ID: 32990596
[TBL] [Abstract][Full Text] [Related]
27. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma.
Zhang S; Tian L; Ma P; Sun Q; Zhang K; GuanchaoWang ; Liu H; Xu B
Arch Oral Biol; 2015 Oct; 60(10):1581-7. PubMed ID: 26276270
[TBL] [Abstract][Full Text] [Related]
28. Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma.
Lin LH; Chang KW; Cheng HW; Liu CJ
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373553
[TBL] [Abstract][Full Text] [Related]
29. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC; Chen BS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
[TBL] [Abstract][Full Text] [Related]
30. Genome-Wide Super-Enhancer-Based Analysis: Identification of Prognostic Genes in Oral Squamous Cell Carcinoma.
Saito T; Asai S; Tanaka N; Nohata N; Minemura C; Koma A; Kikkawa N; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012427
[TBL] [Abstract][Full Text] [Related]
31. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
[TBL] [Abstract][Full Text] [Related]
32. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups.
India Project Team of the International Cancer Genome Consortium
Nat Commun; 2013; 4():2873. PubMed ID: 24292195
[TBL] [Abstract][Full Text] [Related]
33. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the role of microRNAs alterations in oral squamous cell carcinoma.
Aali M; Mesgarzadeh AH; Najjary S; Abdolahi HM; Kojabad AB; Baradaran B
Gene; 2020 Oct; 757():144936. PubMed ID: 32640301
[TBL] [Abstract][Full Text] [Related]
35. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
36. Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology.
Sequeira I; Rashid M; Tomás IM; Williams MJ; Graham TA; Adams DJ; Vigilante A; Watt FM
Nat Commun; 2020 Nov; 11(1):5671. PubMed ID: 33168804
[TBL] [Abstract][Full Text] [Related]
37. Progress in targeted therapeutic drugs for oral squamous cell carcinoma.
Liu L; Chen J; Cai X; Yao Z; Huang J
Surg Oncol; 2019 Dec; 31():90-97. PubMed ID: 31550560
[TBL] [Abstract][Full Text] [Related]
38. [Application value of whole exon sequencing and immune related indicators in the precision treatment of oral squamous cell carcinoma].
Xie S; Cai ZG; Shan XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):697-701. PubMed ID: 37534654
[TBL] [Abstract][Full Text] [Related]
39. Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy.
Lee YM; Hsu CL; Chen YH; Ou DL; Hsu C; Tan CT
Cancer Immunol Res; 2023 Nov; 11(11):1553-1567. PubMed ID: 37669022
[TBL] [Abstract][Full Text] [Related]
40. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers.
Pickering CR; Zhang J; Yoo SY; Bengtsson L; Moorthy S; Neskey DM; Zhao M; Ortega Alves MV; Chang K; Drummond J; Cortez E; Xie TX; Zhang D; Chung W; Issa JP; Zweidler-McKay PA; Wu X; El-Naggar AK; Weinstein JN; Wang J; Muzny DM; Gibbs RA; Wheeler DA; Myers JN; Frederick MJ
Cancer Discov; 2013 Jul; 3(7):770-81. PubMed ID: 23619168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]